These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35801241)

  • 21. Transcriptome analysis of adipocytokines and their-related LncRNAs in lung adenocarcinoma revealing the association with prognosis, immune infiltration, and metabolic characteristics.
    Ren J; Zhang H; Wang J; Xu Y; Zhao L; Yuan Q
    Adipocyte; 2022 Dec; 11(1):250-265. PubMed ID: 35410586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
    Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
    Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M
    Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
    Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma.
    Wu S; Gong Y; Chen J; Zhao X; Qing H; Dong Y; Li S; Li J; Wang Z
    Biol Direct; 2022 Jul; 17(1):19. PubMed ID: 35902970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs.
    Liang P; Li J; Chen J; Lu J; Hao Z; Shi J; Chang Q; Zeng Z
    Sci Rep; 2022 May; 12(1):7162. PubMed ID: 35504892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
    Jung J; Lee YJ; Kim CH; Ahn S
    PLoS One; 2021; 16(3):e0247928. PubMed ID: 33684161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
    Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
    Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma.
    Guo Y; Liu N
    J Oncol; 2022; 2022():5388283. PubMed ID: 36090899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
    Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G
    Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
    Chen M; Liu B; Xiao J; Yang Y; Zhang Y
    Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
    Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
    Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WT1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments.
    Jia M; Shi Y; Xie Y; Li W; Deng J; Fu D; Bai J; Ma Y; Zuberi Z; Li J; Li Z
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma.
    Lv W; Yu X; Li W; Feng N; Feng T; Wang Y; Lin H; Qian B
    Oncol Rep; 2018 Nov; 40(5):2698-2709. PubMed ID: 30132554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.